Opioid prescription patterns among patients who doctor shop; Implications for providers.

作者: Todd Schneberk , Brian Raffetto , Joseph Friedman , Andrew Wilson , David Kim

DOI: 10.1371/JOURNAL.PONE.0232533

关键词:

摘要: Introduction Patients who doctor shop for opioids are a vulnerable population that present difficult dilemma their health care providers regarding best methods of immediate treatment and how to manage risk harm from opioids. We aim describe compare opioid prescription patterns among high quantity patients shopped, did not (doctor shopping eligible patients), the remaining received prescriptions guide policies use patients. Methods performed cross-sectional descriptive analysis during an 8-year period using California’s de-identified Controlled Substance Utilization Review Evaluation System (CURES) database years 2008–2015. identified prevalence shopped depicted including prescriber characteristics, in comparison aforementioned groups. Doctor was defined by greater than 6 or more at least different prescribers within months time. Results Among 3 million individuals period, 1.3% met shopper definition. These levels chronic with 82% 33% averaging 20 100 morphine milligram equivalents (MME) daily, respectively, 72% 18% group. significant proportion MME 1 main (54%) only 2–5% total episodic providers, despite 88% receiving these providers. Conclusions disorder but represent small fraction those dangerous use. Furthermore, do receive substantial which challenges utility reduction programs curbing this population. results suggest we re-evaluate physician roles focus on referral strategies.

参考文章(26)
Edward Bernstein, Judith Bernstein, Suzette Levenson, Project ASSERT: an ED-based intervention to increase access to primary care, preventive services, and the substance abuse treatment system. Annals of Emergency Medicine. ,vol. 30, pp. 181- 189 ,(1997) , 10.1016/S0196-0644(97)70140-9
Tara Gomes, Muhammad M. Mamdani, Irfan A. Dhalla, J. Michael Paterson, David N. Juurlink, Opioid Dose and Drug-Related Mortality in Patients With Nonmalignant Pain Archives of Internal Medicine. ,vol. 171, pp. 686- 691 ,(2011) , 10.1001/ARCHINTERNMED.2011.117
Christopher M. Jones, Karin A. Mack, Leonard J. Paulozzi, Pharmaceutical Overdose Deaths, United States, 2010 JAMA. ,vol. 309, pp. 657- 659 ,(2013) , 10.1001/JAMA.2013.272
Douglas C. McDonald, Kenneth E. Carlson, Estimating the Prevalence of Opioid Diversion by “Doctor Shoppers” in the United States PLoS ONE. ,vol. 8, pp. e69241- ,(2013) , 10.1371/JOURNAL.PONE.0069241
Alex Baldacchino, Gail Gilchrist, Rod Fleming, Jonathan Bannister, Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addictive Behaviors. ,vol. 35, pp. 270- 272 ,(2010) , 10.1016/J.ADDBEH.2009.10.008
Hallam Gugelmann, Jeanmarie Perrone, Lewis Nelson, Windmills and pill mills: can PDMPs tilt the prescription drug epidemic? Journal of Medical Toxicology. ,vol. 8, pp. 378- 386 ,(2012) , 10.1007/S13181-012-0273-8
Aron J Hall, Joseph E Logan, Robin L Toblin, James A Kaplan, James C Kraner, Danae Bixler, Alex E Crosby, Leonard J Paulozzi, Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities JAMA. ,vol. 300, pp. 2613- 2620 ,(2008) , 10.1001/JAMA.2008.802
Kate M. Dunn, Opioid Prescriptions for Chronic Pain and Overdose Annals of Internal Medicine. ,vol. 152, pp. 85- 92 ,(2010) , 10.7326/0003-4819-152-2-201001190-00006
Nathaniel P. Katz, Howard G. Birnbaum, Adam Castor, Volume of prescription opioids used nonmedically in the United States. Journal of Pain and Palliative Care Pharmacotherapy. ,vol. 24, pp. 141- 144 ,(2010) , 10.3109/15360281003799098